Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

Investigating the role of Fusobacterium nucleatum and other oncomicrobes in colorectal cancer

FY 2018-19

Summary
Fusobacterium nucleatum is an anaerobic bacterium that is ubiquitous in the human oral cavity, but has been isolated from extra-oral body sites in numerous diseased states. F. nucleatum has been implicated in a broad range of infections and diseases, such as colorectal cancer. This bacterial species has several virulence determinants, including the ability to adhere to and invade human cells, such as colon carcinomas. The purpose of my research is to elucidate the colorectal cancer-promoting role of F. nucleatum, and to investigate the suitability of the murine model for F. nucleatum-associated human colorectal cancer. I hypothesize that equivalent representative murine and human cell lines will exhibit similar cancer-promoting gene expression when infected with F. nucleatum. Additionally, I hypothesize that the host cell response is modulated by the surrounding colon microbiome. My first objective is to characterize the modulation in gene expression of both F. nucleatum and noncancerous human host cells by dual RNA-seq bioinformatics (where fusobacterial and host mRNA are sequenced in tandem). My second objective is to determine the modulation in gene expression of both F. nucleatum and noncancerous murine host cell lines that parallel the noncancerous human cell lines, also by dual RNA-seq. My third objective is to determine whether F. nucleatum works synergistically with other “oncomicrobes”—microbes associated with oncogenesis—and if F. nucleatum can be antagonized by members of the normal colonic microbiota. This objective will be investigated by analyzing the gene expression of both multi-bacterial species infections of host cells, and by infecting host cells with F. nucleatum in the presence of metabolites derived from representative healthy gut microbiomes.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406610
Name
Robinson Avery
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Fusobacterium nucleatum and other oncomicrobes in colorectal cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacterial Infection; Bioinformatics; Cancer Biomarkers; Colorectal Cancer; Fusobacterium Sp.; Gene Expression; Human Microbiome; Murine Cancer Model; Oncogenesis; Pathogenesis
Abstract
Fusobacterium nucleatum is an anaerobic bacterium that is ubiquitous in the human oral cavity, but has been isolated from extra-oral body sites in numerous diseased states. F. nucleatum has been implicated in a broad range of infections and diseases, such as colorectal cancer. This bacterial species has several virulence determinants, including the ability to adhere to and invade human cells, such as colon carcinomas. The purpose of my research is to elucidate the colorectal cancer-promoting role of F. nucleatum, and to investigate the suitability of the murine model for F. nucleatum-associated human colorectal cancer. I hypothesize that equivalent representative murine and human cell lines will exhibit similar cancer-promoting gene expression when infected with F. nucleatum. Additionally, I hypothesize that the host cell response is modulated by the surrounding colon microbiome. My first objective is to characterize the modulation in gene expression of both F. nucleatum and noncancerous human host cells by dual RNA-seq bioinformatics (where fusobacterial and host mRNA are sequenced in tandem). My second objective is to determine the modulation in gene expression of both F. nucleatum and noncancerous murine host cell lines that parallel the noncancerous human cell lines, also by dual RNA-seq. My third objective is to determine whether F. nucleatum works synergistically with other “oncomicrobes”—microbes associated with oncogenesis—and if F. nucleatum can be antagonized by members of the normal colonic microbiota. This objective will be investigated by analyzing the gene expression of both multi-bacterial species infections of host cells, and by infecting host cells with F. nucleatum in the presence of metabolites derived from representative healthy gut microbiomes.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robinson, Avery
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~